Our previous studies have shown that the expression of heme synthetis enzymes such as ALAS1 and heme degradation enzyme like HO-2 is significantly reduced in human AD brains compared to control brains 31, 36. This evidence concerns the gene ALAS1 and Alzheimer disease.